Carcinoid syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 12: Line 12:
* Karzinoide or “[[carcinoma]]-like” describes the unique feature of behaving like a [[benign]] [[tumor]] despite resembling a [[carcinoma]] microscopically.
* Karzinoide or “[[carcinoma]]-like” describes the unique feature of behaving like a [[benign]] [[tumor]] despite resembling a [[carcinoma]] microscopically.
* Rapport and colleagues isolated and named [[serotonin]] [[5-HT|(5-HT]]), initially identified as a [[vasoconstrictor]] [[substance]] in the [[serum]].<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref>
* Rapport and colleagues isolated and named [[serotonin]] [[5-HT|(5-HT]]), initially identified as a [[vasoconstrictor]] [[substance]] in the [[serum]].<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref>
* [[Enterochromaffin]] [[Cell|cel]]<nowiki/>l,the [[cell]] of origin of [[carcinoid tumour]] had been identified as early as 1897 by N. Kulchitsky (1856-1925).
*<nowiki/>[[Enterochromaffin]] [[Cell|cel]]<nowiki/>l,the [[cell]] of origin of [[carcinoid tumour]] had been identified as early as 1897 by N. Kulchitsky (1856-1925).
* F. Lembeck in 1953 established that [[enterochromaffin]] [[cells]] synthesizes and secretes [[serotonin]] and a major [[hormone]] responsible for [[Carcinoid Syndrome|carcinoid syndrome.]]<ref name="pmid14941051">{{cite journal |vauthors=ERSPAMER V, ASERO B |title=Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine |journal=Nature |volume=169 |issue=4306 |pages=800–1 |date=May 1952 |pmid=14941051 |doi= |url=}}</ref><ref name="pmid16882492">{{cite journal |vauthors=Sippel RS, Chen H |title=Carcinoid tumors |journal=Surg. Oncol. Clin. N. Am. |volume=15 |issue=3 |pages=463–78 |date=July 2006 |pmid=16882492 |doi=10.1016/j.soc.2006.05.002 |url=}}</ref>
* In 1953, F. Lembeck <nowiki/>established that [[enterochromaffin]] [[cells]] synthesizes and secretes [[serotonin]], the major [[hormone]] responsible for [[Carcinoid Syndrome|carcinoid syndrome.]]<ref name="pmid14941051">{{cite journal |vauthors=ERSPAMER V, ASERO B |title=Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine |journal=Nature |volume=169 |issue=4306 |pages=800–1 |date=May 1952 |pmid=14941051 |doi= |url=}}</ref><ref name="pmid16882492">{{cite journal |vauthors=Sippel RS, Chen H |title=Carcinoid tumors |journal=Surg. Oncol. Clin. N. Am. |volume=15 |issue=3 |pages=463–78 |date=July 2006 |pmid=16882492 |doi=10.1016/j.soc.2006.05.002 |url=}}</ref>


==References==
==References==

Latest revision as of 20:55, 30 April 2019

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome historical perspective

CDC on Carcinoid syndrome historical perspective

Carcinoid syndrome historical perspective in the news

Blogs on Carcinoid syndrome historical perspective

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

The term Carcinoid was given by Siegfried Oberndorfer, a German pathologist at the University of Munich in 1907. Enterochromaffin cell, the cell of origin of carcinoid tumour had been identified as early as 1897 by N. Kulchitsky.

Historical Perspective

References

  1. RAPPORT MM, GREEN AA, PAGE IH (December 1948). "Serum vasoconstrictor, serotonin; isolation and characterization". J. Biol. Chem. 176 (3): 1243–51. PMID 18100415.
  2. ERSPAMER V, ASERO B (May 1952). "Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine". Nature. 169 (4306): 800–1. PMID 14941051.
  3. Sippel RS, Chen H (July 2006). "Carcinoid tumors". Surg. Oncol. Clin. N. Am. 15 (3): 463–78. doi:10.1016/j.soc.2006.05.002. PMID 16882492.

Template:WH Template:WS

References

Template:WS Template:WH